Usefulness of bucindolol in congestive heart failure

The American Journal of Cardiology

Volumn 66, Issue 5, 1990, Pages 603-607

  Pollock, Stewart G ^a   Lystash, John ^a   Tedesco, Christine ^a   Craddock, George ^a   Smucker, Mark L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUCINDOLOL;

ARTICLE; CLINICAL ARTICLE; EXERCISE; FOLLOW UP; HEART FAILURE; HEMODYNAMICS; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; DOUBLE-BLIND METHOD; DRUG EVALUATION; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGE; PROPANOLAMINES; RANDOMIZED CONTROLLED TRIALS; SUPPORT, NON-U.S. GOV'T; VASODILATOR AGENTS;

EID: 0025076439     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(90)90488-M     Document Type: Article

References (14)

1. Decreased catecholaminc sensitivity and beta-adrenergic-receptor density in failing human hearts
2. Effect of chronic betaadrenergic receptor blockade in congestive cardiomyopathy
3. Are beta-adrenergic-blocking drugs useful in the treatment of dilated cardiomyopathy?
4. Effect of beta blockers on vascular resistance in systemic hypertension
5. Hemodynamic properties of bucindolol a beta-adrenoreceptor blocking drug with vasodilator activity
6. Studies on the vasodilator actions of bucindolol in the rat
7. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study
8. Effects of enalapril on mortality in severe congestive heart failure Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
9. Six minute walking test for assessing exercise capacity in chronic heart failure
10. Long-term β-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo
11. Acute hemodynamic effects of pindolol and propranolol in patients with dilated cardiomyopathy. Relevance of intrinsic sympathomimetric activity
12. Bergh C-H, Hjalmarson A. Long-term β-blockade in dilated cardiomyopathy
13. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy
14. Hemodynamic-inotropic response to beta-blocker with intrinsic sympathomimetic activity in patients with congestive cardiomyopathy